Azithromycin + Ampicillin/sulbactam
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Pneumonia
Conditions
Pneumonia
Trial Timeline
Nov 1, 2003 → Sep 1, 2005
NCT ID
NCT00137007About Azithromycin + Ampicillin/sulbactam
Azithromycin + Ampicillin/sulbactam is a approved stage product being developed by Pfizer for Pneumonia. The current trial status is completed. This product is registered under clinical trial identifier NCT00137007. Target conditions include Pneumonia.
What happened to similar drugs?
4 of 20 similar drugs in Pneumonia were approved
Approved (4) Terminated (3) Active (14)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00137007 | Approved | Completed |
Competing Products
20 competing products in Pneumonia